Contents

Current Cancer Therapy Reviews, Volume 13 - Number 1

Editorial

Meet Our Editorial Board Member

, 13(1): 1

John F. Deeken


DOI: 10.2174/157339471301170829115741




Preface

Preface

, 13(1): 2

Kurt S. Zaenker


DOI: 10.2174/157339471301170829120019




Review Article

Erlotinib: A Targeted Anticancer Drug

, 13(1): 3 - 16

Parijat Pandey and Harish Dureja


DOI: 10.2174/1573394713666170522181615





Review Article

Cancer and Treatment Modalities

, 13(1): 17 - 27

Elham Hosseinzadeh, Nooshin Banaee and Hassan Ali Nedaie


DOI: 10.2174/1573394713666170531081818





Review Article

Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

, 13(1): 28 - 42

Ravinesh Mishra, Swati Sareen, Bhartendu Sharma, Shubham Goyal, Gurpreet Kaur, Sweta Bhardwaj, Anees A. Siddiqui, Asif Husain, Rajeev K. Singla, Mohd Rashid, Deepak Kumar, Bhawana Sati, Nishtha Shalmali and Rajiv Kumar


DOI: 10.2174/1573394713666170524122904





Review Article

Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma

, 13(1): 43 - 62

Ankita Maji, Sachin M and Dwaipayan Sen


DOI: 10.2174/1573394713666170525144104





Review Article

Targeted Nanosystems for Cancer Therapy

, 13(1): 63 - 73

Ruhee Jain, Tahseen Khan, Sourabh Jain, Ashutosh Pal Jain and Aakanchha Jain


DOI: 10.2174/1573394713666170622104347





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science